https://biotechmorning.com/news/nutshell-therapeutics-nts231-triple-mechanism-degrader Biotech Morning en 2026-09-26T14:17:54.686Z The Drug That Breaks Three Rules at Once Just Got Its Shot https://biotechmorning.com/news/eli-lilly-90m-nektar-unwritten-rule Biotech Morning en 2026-09-26T14:17:07.638Z Eli Lilly Just Lost $90M for Breaking an Unwritten Rule https://biotechmorning.com/news/child-died-china-gene-editing-trial-transparency Biotech Morning en 2026-09-26T14:16:21.615Z A Child Died in a Chinese Gene-Editing Trial. The World Found Out a Year Later. https://biotechmorning.com/news/fop-zilurgisertib-fda-approval-mirum Biotech Morning en 2026-09-26T14:15:36.012Z The Disease That Turns You Into a Statue Just Got Its Newest Enemy https://biotechmorning.com/news/merck-daiichi-sankyo-second-fda-withdrawal Biotech Morning en 2026-09-26T14:14:54.377Z Merck and Daiichi Sankyo's $22 Billion Bet Just Hit Its Second Speed Bump https://biotechmorning.com/news/abbvie-iambic-ai-drug-discovery-deal Biotech Morning en 2026-09-26T14:14:08.523Z AbbVie Just Bet Big on a Robot Chemist Backed by Nvidia https://biotechmorning.com/news/china-newco-consultant-double-dealing-lawsuit Biotech Morning en 2026-09-26T14:13:25.245Z The Consultant Who Played Both Sides of China's Hottest Biotech Deal Machine https://biotechmorning.com/news/boehringer-billion-dollar-rna-splicing-envisagenics Biotech Morning en 2026-09-26T14:12:36.035Z Boehringer's Billion-Dollar Bet on Biology's Best-Kept Secret https://biotechmorning.com/news/novo-nordisk-nanexa-pharmashell-deal Biotech Morning en 2026-09-26T14:11:45.844Z Novo Nordisk Just Paid $1.3B for a Coating Thinner Than a Soap Bubble https://biotechmorning.com/news/parkinsons-first-new-dopamine-drug-type-decades Biotech Morning en 2026-09-26T14:10:59.502Z Parkinson's Gets Its First New Type of Dopamine Drug in Decades https://biotechmorning.com/news/gene-therapy-sanfilippo-syndrome-fda-approval Biotech Morning en 2026-09-26T14:10:14.400Z The $3.9 Million Shot That Could Save Kids With No Other Options https://biotechmorning.com/news/first-drug-cerebral-adrenoleukodystrophy-nezglyal Biotech Morning en 2026-09-25T14:14:59.089Z The First Drug for a Disease That Had Zero https://biotechmorning.com/news/adarx-half-billion-dollar-ipo-bet-silencing-genes Biotech Morning en 2026-09-25T14:14:16.835Z A Half-Billion-Dollar Bet on Silencing Genes https://biotechmorning.com/news/merck-kgaa-bio-techne-acquisition-picks-shovels-biotech Biotech Morning en 2026-09-25T14:13:33.673Z Merck KGaA Just Made a $11.3 Billion Bet on the Picks and Shovels of Biotech https://biotechmorning.com/news/end-of-daily-insulin-shots-finally-here Biotech Morning en 2026-09-25T14:12:51.736Z The End of Daily Insulin Shots Is Finally Here https://biotechmorning.com/news/acadia-alzheimers-drug-phase-2-miss-phase-3-anyway Biotech Morning en 2026-09-25T14:12:09.821Z Acadia's Alzheimer's Drug Missed by a Hair. They're Going to Phase 3 Anyway. https://biotechmorning.com/news/biogen-fda-breakthrough-designation-crl-sma Biotech Morning en 2026-09-25T14:11:21.571Z Biogen's Wild Day: An FDA Gold Star and a Rejection Letter, Both for SMA https://biotechmorning.com/news/genentech-earendil-bispecific-antibody-deal Biotech Morning en 2026-09-25T14:10:33.929Z Genentech Just Paid $55M for a Ticket Worth $1.5 Billion https://biotechmorning.com/news/one-shot-cholesterol-epigenetic-pcsk9-silencing Biotech Morning en 2026-09-25T14:09:47.093Z One Shot to Kill Your Cholesterol. Forever. https://biotechmorning.com/news/merck-belzutifan-lenvatinib-kidney-cancer-fda-approval Biotech Morning en 2026-09-25T14:08:57.956Z Merck Just Found Kidney Cancer's Double Lock (and the Two Keys to Open It) https://biotechmorning.com/news/carvykti-five-year-remission-multiple-myeloma Biotech Morning en 2026-09-25T14:08:13.673Z One Shot. Five Years. Half of These Cancer Patients Are Still in Remission.